Health Condition 1: C01- Malignant neoplasm of base of tongue Health Condition 2: C031- Malignant neoplasm of lower gum
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: American Society of Anesthesiologists physical status (ASA PS) 2 to 3, Carcinoma tongue and alveolus undergoing tumor resection surgeries requiring nasal intubation
Exclusion criteria
Exclusion criteria: i.Patients with basal HR ii.on beta blockers, iii.having cardiac arrhythmias, heart blocks, congestive heart failure, iv.liver disorders with aspartate aminotransferase /alanine transaminase >2-3 times normal v.renal diseases with estimated glomerular filtration rate vi.hypersensitivity to lignocaine vii.awake fiberoptic bronchoscope assisted intubation, viii.carcinoma maxilla, craniofacial resection, exenteration, scalp, mastoid and surgeries requiring neuro assistance ix.supplemental regional anaesthesia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective is to compare the endtidal sevoflurane concentration required to maintain intraoperative bispectoral index (BIS) values between 40 to 60 au in patients receiving opioid free anesthesia (OFA) using intravenous lignocaine versus standard regimen using morphine during tumor resection in patients with head and neck malignancies undergoing wide excision and reconstruction surgeries.Timepoint: at start to end of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)comparison of BIS during induction, nasal intubation and anastomosis of free flap, 2)intraoperative changes in heart rate and mean arterial pressure, 3)consumption of sevoflurane, need for additional analgesic like low dose ketamine or dexmedetomidine, 4)incidence of hypertension, hypotension, arrhythmia, bradycardia, 5)intraoperative awareness, 6)need to stop intravenous lignocaine in OFA patients, 7)need for vasopressors or inotropes in both groups.Timepoint: start of surgery to end of surgery | — |
Countries
India
Contacts
AMRITA INSTITUTE OF MEDICAL SCIENCES